These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15764896)

  • 41. Primary synovial sarcoma of the kidney: use of PET/CT in diagnosis and follow-up.
    Erturhan S; Seçkiner I; Zincirkeser S; Erbagci A; Celik M; Yagci F; Karakok M
    Ann Nucl Med; 2008 Apr; 22(3):225-9. PubMed ID: 18498039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic value of
    Kassem TW; Abdelaziz O; Emad-Eldin S
    Diagn Interv Imaging; 2017 Oct; 98(10):693-698. PubMed ID: 28734778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
    Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ
    Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metastatic undifferentiated spindle cell sarcoma of the thyroid gland evaluated by 18F-FDG PET/CT.
    Treglia G; Bongiovanni M; Paone G; Ceriani L; Giovanella L
    Clin Nucl Med; 2015 Mar; 40(3):e208-10. PubMed ID: 25140545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiological features of synovial cell sarcoma.
    O'Sullivan PJ; Harris AC; Munk PL
    Br J Radiol; 2008 Apr; 81(964):346-56. PubMed ID: 18250123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Missed causative tumors in diagnosing tumor-induced osteomalacia with (18)F-FDG PET/CT: a potential pitfall of standard-field imaging.
    Kaneuchi Y; Hakozaki M; Yamada H; Hasegawa O; Tajino T; Konno S
    Hell J Nucl Med; 2016; 19(1):46-8. PubMed ID: 26929940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary peripheral neurolymphomatosis mimicking synovial sarcoma: FDG PETCT to the rescue.
    Padma S; Sundaram PS; Praveen Kumar SL
    J Cancer Res Ther; 2014; 10(3):726-9. PubMed ID: 25313768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. F-18 FDG PET imaging of metastases from soft tissue myoepithelioma.
    Nguyen BD
    Clin Nucl Med; 2005 Mar; 30(3):201-2. PubMed ID: 15722831
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
    Roh JL; Ryu CH; Kim JS; Lee JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Sep; 43(8):757-63. PubMed ID: 17112773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is FDG-PET/CT Useful for Diagnosing Pulmonary Metastasis in Patients with Soft Tissue Sarcoma?
    Hagi T; Nakamura T; Sugino Y; Matsubara T; Asanuma K; Sudo A
    Anticancer Res; 2018 Jun; 38(6):3635-3639. PubMed ID: 29848720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FDG uptake in a rheumatoid nodule with imaging appearance similar to a malignant soft tissue tumor.
    Strobel K; von Hochstetter AR; Exner UG
    Clin Nucl Med; 2009 Oct; 34(10):691-2. PubMed ID: 19893403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract.
    Kim MR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2008 Feb; 44(2):148-52. PubMed ID: 17350879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extensive F-18 FDG uptake in metastatic spindle cell carcinoma of the lung.
    Verreault J; Turcotte E; Benard F; Mongeau CJ; Boileau R
    Clin Nucl Med; 2001 Jan; 26(1):79-80. PubMed ID: 11139069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preoperative FDG PET/CT in breast cancer patients: where are we going?
    Gilardi L; De Cicco C; Paganelli G
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1667-9. PubMed ID: 22976500
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of Whole-Body (18)F FDG PET/MR Imaging and Whole-Body (18)F FDG PET/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer.
    Melsaether AN; Raad RA; Pujara AC; Ponzo FD; Pysarenko KM; Jhaveri K; Babb JS; Sigmund EE; Kim SG; Moy LA
    Radiology; 2016 Oct; 281(1):193-202. PubMed ID: 27023002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Varying degrees of FDG uptake in multiple benign neurofibromas on PET/CT.
    Son JM; Ahn MI; Cho KD; Yoo J; Park YH
    Br J Radiol; 2007 Sep; 80(957):e222-6. PubMed ID: 17928494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multifocal epithelioid hemangioendothelioma of the lower limbs detected by 18F-FDG PET/MRI.
    Treglia G; Ceriani L; Paone G; Rusca T; Bongiovanni M; Giovanella L
    Clin Nucl Med; 2014 Sep; 39(9):e402-4. PubMed ID: 24445271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Positron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: A meta-analysis.
    Li YJ; Dai YL; Cheng YS; Zhang WB; Tu CQ
    Eur J Surg Oncol; 2016 Aug; 42(8):1103-14. PubMed ID: 27189833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synovial sarcoma arising from the chest wall: MR imaging findings.
    Fujimoto K; Hashimoto S; Abe T; Meno S; Terasaki H; Nishimura H; Hayabuchi N
    Radiat Med; 1997; 15(6):411-4. PubMed ID: 9495793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas.
    Schwarzbach MH; Hinz U; Dimitrakopoulou-Strauss A; Willeke F; Cardona S; Mechtersheimer G; Lehnert T; Strauss LG; Herfarth C; Büchler MW
    Ann Surg; 2005 Feb; 241(2):286-94. PubMed ID: 15650639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.